Jiangsu Canopus Wisdom Medical Technology Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Jiangsu Dongxing Intelligent Medical Technology Co., Ltd., formerly known as Jiangsu Dongxing Medical Equipment Co., Ltd., was established in February 2001. In July 2015, the company completed a shareholding transformation based on its own development strategy layout and officially renamed Jiangsu Dongxing Smart Medical Technology Co., Ltd. (hereinafter referred to as "Dongxing Medical"). In December 2015, Dongxing Medical was successfully listed on the National Equities Exchange System (hereinafter referred to as the "National Equities Exchange System" or the "New Third Board") with the stock code of 834478. According to the National Economic Industry Classification (GB/T4754-2017), the company currently belongs to the industry of "C3584- Specialized Equipment Manufacturing - Medical Instrument and Equipment Manufacturing - Medical, Surgical, and Veterinary Equipment Manufacturing". The company currently has four business segments: surgical agency equipment, research and development and production of surgical equipment, research and development and production of surgical equipment components, and research and development and production of surgical equipment. The company has been deeply involved in the field of minimally invasive surgical medical devices for a long time, continuously expanding its product line through endogenous development and external expansion. Starting from the initial agency sales of well-known domestic and foreign brands of surgical medical devices, it has gradually developed into a platform based group company represented by high-end surgical endoscopic staplers and their accessories, covering multiple categories of minimally invasive surgical equipment and equipment. After the company was listed on the New Third Board market, it adhered to the development strategy of "industry oriented and finance oriented", fully utilized the capital market, and successively acquired Suzhou Sanfeng Original Medical Technology Co., Ltd., Changzhou Weike Medical Equipment Co., Ltd., and Jiangsu Zihang Precision Hardware Co., Ltd. From a single sales oriented enterprise, it completed the transformation into a comprehensive enterprise that integrates production, research and development, and sales, Realized the closed-loop of the industrial chain and the construction of new business models; At the same time, the company's Dongxing Smart Medical Industrial Park officially began construction in May 2019, with a total construction area of 65000 square meters. It is planned to build two research and development workshops and three production workshops, providing favorable conditions for the company's subsequent collaborative office and scientific research innovation, and laying a solid foundation for stable development and industry expansion in the future. The company has always attached great importance to scientific research investment and focused on research and innovation. Its subsidiaries Changzhou Weike Medical Equipment Co., Ltd. and Jiangsu Zihang Precision Hardware Co., Ltd. are both high-tech enterprises in Jiangsu Province; The parent and subsidiary companies at all levels have obtained a total of 101 technical patents, among which the "unequal height nail" patent independently developed by Weike Medical is the first in China, guiding the overall update and iteration of the stapler product; The subsidiary Weike Medical established the "Changzhou Postdoctoral Innovation Practice Base" in May 2019, promoting the integrated development of industry, academia, and research, realizing the industrialization of scientific and technological achievements, and continuously updating and iterating stapler products using high-tech; The first drafting unit for the TC94-2019 industry standard "Endoscopic Surgical Instruments, Endoscopic Cutting Staplers and Components" document of the subsidiary Weike Medical Stapler Industry has significant influence in the development of industry standards in the field of stapler segmentation; The subsidiary Zihang Precision specializes in the research, development, production, and sales of stapler and puncture device components, with the manufacturing and processing capabilities of a full range of stapler products. With the development of the stapler industry, it has formed a new industry field for the processing and manufacturing of stapler components, covering more than 70% of domestic stapler manufacturers. In September 2020, based on its strategic goals and combined with its own business development, the company submitted materials for terminating its listing to the National Stock Transfer System and submitted application materials for IPO guidance on the Growth Enterprise Market to the Jiangsu Securities Regulatory Bureau. Currently, it has officially entered the guidance period. In November 2020, the company received a letter from the National Equities Exchange System approving the termination of listing of Jiangsu Dongxing Smart Medical Technology Co., Ltd.'s shares on the National Equities Exchange System. The company's shares were terminated on the National Equities Exchange System from November 20, 2020. At present, the company is actively planning and promoting the initial public offering of stocks and listing on the ChiNext. Dongxing Medical always adheres to the code of conduct of "pursuing perfection and continuous innovation", sharing high-quality products, and is committed to providing surgeons with comprehensive surgical solutions with advanced surgical instruments, professional medical education, and high-quality customer service. Long winds and waves may come and go, and Dongxing Medical will continue to forge ahead, innovate bravely, prioritize integrity, and prioritize quality in its future development. We aspire to become a leader in the field of surgical and medical equipment in China. |
| Headquarter | Changzhou |
| Establish Date | 2/21/2001 |
| Listed Code | 301290.SZ |
| Listed Date | 11/30/2022 |
| Chairman | Wan Shiping. |
| CEO | Wei Jiangang. |
| Website | www.dx-med.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
